The oncogenic effect of NF-κB in BC was associated with cell proliferation induction by activating granulocyte–macrophage colony-stimulating factor (GM-CSF), IL-2, cyclin D1, and CD40 ligand (CD40L). Here, NFKB1 is linked to breast cancer.